Tuesday, March 17, 2026

Three misconceptions that limit point-of-care marketing impact

Point of care (POC) has long been treated as a decisive moment in healthcare, where professional interaction and clinical context can influence what happens next. In life sciences marketing, the term has also broadened over time from its earlier diagnostic roots into a label for activation around care situations. As care delivery changes, however, the practical meaning of “point of care” is changing with it.

Care is no longer confined to physician offices, hospitals, and pharmacies. Telehealth, digital health services, retail care formats, and home delivery models expand the settings in which treatment is initiated or managed. At the same time, more companies are positioning themselves as POC solution providers, while marketers face increasing uncertainty about which tactics and channels actually drive outcomes.

There is no universal POC blueprint. The most useful approach is to align investments with where and when a brand is truly prescribed. Three common misconceptions can derail that planning.

1. Point of care always means point of prescribing

As the POC ecosystem expands, more touchpoints emerge that do not combine patient presence, an HCP, and an immediate care decision. For brands that prioritize prescription-related KPIs, the distance to the decision moment matters.

Channels often grouped under POC can differ substantially in how close they are to prescribing. Telehealth portals, clinical decision support, and EHR environments can reach HCPs in clinical contexts, but vary in timing, targeting options, and proximity to the decision itself. When programs overemphasize settings that mainly build awareness, impact on prescribing can be harder to achieve.

2. Reach and CPM are the biggest drivers of value

POC investment decisions are frequently shaped by metrics such as list match rates and CPMs. While cost efficiency matters, optimizing primarily for scale can work against the core advantage of POC.

POC is valued for relevance and context: reaching an HCP when they are managing an appropriate patient situation. When reach and cost dominate the brief, partners may be pushed toward volume over precision, reducing the likelihood that messaging appears at the most meaningful moments. With limited budgets, spreading impressions too broadly can also leave high-opportunity prescribers under-served. Marketers may additionally find that reach expectations become difficult to realize once budget and targeting constraints are applied.

3. POC activation and measurement are inherently a black box

POC offerings can bundle multiple systems and distribution routes, which makes programs complex. Complexity, however, should not be used to justify limited transparency. Missing channel-level delivery detail or the absence of NPI-level reporting can be a sign that premium pricing is being applied without clear proof of where impressions ran.

Restrictions on third-party measurement or tagging should also prompt scrutiny, since they reduce the ability to verify delivery. Beyond budget risk, limited transparency can create compliance exposure. When approvals rely on clear business rules for targeting and activation, unclear deployment can introduce questions that are difficult to answer in audits or regulatory discussions.

POC should be treated as a strategy, not just a channel

POC is not simply another line in the media plan. Its value depends on precise execution, verifiable delivery, and alignment with real-world prescribing pathways. In a market with more vendors and more formats, marketers benefit from pressure-testing promises, demanding clear reporting, and insisting on measurement that matches the price and the risk profile of the activity.